KYOWA HAKKO BIO CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
5
Active:1
Completed:4
Trial Phases
1 Phases
Not Applicable:5
Drug Approvals
8
NMPA:8
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (100.0%)Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
Not Applicable
Active, not recruiting
- Conditions
- Gastrointestinal DiseasesHealthy
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Kyowa Hakko Bio Co., Ltd.
- Target Recruit Count
- 108
- Registration Number
- NCT06094153
- Locations
- 🇸🇬
Singapore Institute for Clinical Trials, Singapore, Singapore
The Combination Effect of Citicoline and Omega-3
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2018-02-23
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Kyowa Hakko Bio Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT03444662
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Kyowa Hakko Bio Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT03369925
- Locations
- 🇺🇸
Biofortis Clinical Research, Inc., Addison, Illinois, United States
Citicoline Effects on Cortical Membrane Structure and Function
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- Kyowa Hakko Bio Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT02705066
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
News
No news found